Ex-Kellogg U.K. marketer steps into boots global post

Published on .

LONDON -- Boots Healthcare International, the U.K.-based over-the-counter medicine specialist that owns global healthcare brands such as Nurofen and Strepsils, has recruited ex-Kellogg U.K. marketing director Rob Morgan as its worldwide director of marketing.

Morgan will from next January be responsible for driving the marketing efforts behind BHI's expansion into new international markets and new products. The company already sells its products in 120 markets around the world from businesses in 15 countries.

In the last year, it spent more than $125m on developing and marketing new products, including over 20 new launches in different national markets. This September, BHI bought French skincare specialist Laboratoires Lutsia - owners of the Lutsine and Onagrine brands - from Roussel Uclaf for $194m.

During his eight years at Kellogg, where he headed the marketing operation for U.K. brands until 1995, Morgan was highly rated. His blue-chip fmcg experience - with General Foods and Cadbury before that - made his departure for the managing director position at Turtle Wax International last year an unlikely move.

He replaces Peter Millburn, who has moved within the Boots Company to its new business venture in Japan.

Copyright November 1996, Crain Communications Inc.

Most Popular
In this article: